Oksana I. Kauk

Oksana I. Kauk

Auto-generated profile, based on publicly available information

Oksana I. Kauk

Kharkiv National Medical University, Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Psychiatry, Neurology and Medical Psychology
Verified
Journal Article
Open access
PDF file
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
OKO.I. Kauk
O.I. Kauk
Background. For a long time, clinical neuroscience has primarily focused on severe forms of alcohol-related encephalopathy, which are typically associated with pronounced dependency and macroscopic brain changes. However, recent interdisciplinary studies demonstrate that even regular moderate alcohol consumption without signs of dependence can initiate chronic morphofunctional changes in cortical brain structures. This has led to the identification of a new phenotype: Silent Neurotoxicity Syndrome (SNS), characterized by subclinical neuropsychological shifts, neuroinflammation, impaired neuroplasticity, and dysfunction in neuro-glio-capillary interaction. Purpose – of this study is to examine the clinical-functional, neuropsychological, and macromorphophysiological manifestations of latent cortical neurodegeneration in socially adapted patients with regular moderate alcohol consumption and no diagnosis of alcohol dependence, as well as to substantiate SNS as a distinct subtype of chronic alcohol-induced encephalopathy. Materials and Methods. A qualitative interdisciplinary study was conducted using in-depth semi-structured interviews (n=24, of which 20 met inclusion criteria), neuropsychological screenings (MMSE), and a systematic literature review across PubMed, Scopus, and Web of Science databases using relevant keywords. Special attention was paid to the phenomenon of compensatory alcohol use, the presence of subclinical complaints, and the formation of alcohol-modulated behavior. Results. Cognitive changes (such as reduced executive functioning, concentration, and attention) were found in 40% of participants, emotional-motivational disturbances in 30%, and visuospatial deficits in 25%. Neurophysiological mechanisms of SNS were described, including decreased BDNF levels, inhibition of synaptic plasticity, microglial activation, glio-capillary barrier dysfunction, and microatrophy in the prefrontal cortex and hippocampus. A staged model of SNS development was proposed: prodromal, latent, subclinical, and advanced latent stages. Transdisciplinary analysis confirmed that even low-dose regular alcohol consumption can lead to persistent neuromorphological changes in the absence of clinical dependence. Conclusions. Silent Neurotoxicity Syndrome is a newly identified subtype of alcoholinduced encephalopathy, marked by hidden but progressive damage to neuronalglial structures. It evades detection by standard diagnostic tools yet poses a significant threat to cognitive reserve and emotional regulation. The clinical implementation of SNS requires an update in the assessment of «safe» alcohol consumption, the inclusion of neuroplasticity screenings, and the development of early preventive strategies at preclinical stages.

29 August 2025 in Psychiatry, Neurology and Medical Psychology
Verified
Journal Article
Open access
PDF file
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
OKO.I. Kauk
O.I. Kauk
SSS.O. Stetsenko
S.O. Stetsenko
OPO.M. Pliten
O.M. Pliten
Background. Acute respiratory infections (ARIs) in children are commonly accompanied by asthenovegetative symptoms, such as lethargy, irritability, and cardiovascular dysregulation. However, the underlying pathophysiological mechanisms remain insufficiently understood. Purpose – to examine the relationship between the intensity of systemic inflammatory response and neurological manifestations in pediatric ARIs, with a particular focus on neuro-glio-capillary dysfunction as a key pathophysiological link. Materials and methods. A prospective clinical study was conducted involving 40 children aged 2–12 years, categorized into three groups: Group A (n=15) included children with uncomplicated viral respiratory infections and CRP levels of 1–7 mg/L; Group B (n=15) comprised children with confirmed bacterial respiratory infections and CRP ≥ 8 mg/L; Group C (n=10) served as a healthy control group with CRP < 1 mg/L. All participants underwent comprehensive neurological examination, measurement of vital parameters, pulse oximetry, and laboratory testing. Comparative statistical analysis of symptom frequency and severity between groups was performed using the Mann–Whitney U test. Results. Group A demonstrated predominantly functional and mild neurological symptoms, including lethargy (73%), mild tachycardia (40%), and increased tactile sensitivity (27%), with all children maintaining normal consciousness and oxygen saturation > 95%. In contrast, Group B showed significantly more pronounced manifestations, including impaired consciousness (33%), oxygen desaturation down to 88–90% in 27% of patients, motor disturbances such as hypotonia and coordination disorders (20% each), and more severe autonomic signs (tachycardia in 80%). The average number of neurological symptoms per patient was significantly higher in Group B compared to Group A. A temperature threshold of approximately 39.0°C was identified, beyond which signs of neuro-glio-capillary decompensation occurred, particularly in bacterial infections. Dehydration, observed in 33% of Group B, was strongly associated with the most severe neurological manifestations. Conclusions. This study highlights neuro-glio-capillary dysfunction as a key mechanism in the development of asthenovegetative symptoms in pediatric ARIs. A clear correlation was established between systemic inflammation markers (CRP levels), oxygen saturation, febrile response, and the severity of neurological involvement. CRP levels exceeding 8 mg/L, hyperthermia >39.0°C, and oxygen saturation < 90% may serve as early predictors of significant neuro-glio-capillary impairment. These findings underscore the importance of integrated clinical monitoring – including inflammatory markers, oxygenation status, hydration, and neurological function – for early detection and prevention of potential complications in children with ARIs.

30 June 2025 in Psychiatry, Neurology and Medical Psychology
Verified
Journal Article
Open access
PDF file
OKO.I. Kauk
O.I. Kauk
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
DKD.YE. Kulyk
D.YE. Kulyk
ДКД.є. Кулик
Д.є. Кулик
Background. Inflammatory biomarkers play a critical role in the early diagnosis, prognosis, and clinical management of patients with ischemic stroke, particularly in intensive care settings. Purpose – conduct a systematic summary and meta-analysis of existing clinical studies in order to assess the prognostic value of inflammatory biomarkers – C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin (PCT) – in patients with ischemic stroke who were hospitalized in intensive care units, taking into account their impact on clinical outcomes, severity of condition, risk of complications, and mortality. Materials and methods. A systematic literature review was conducted, analyzing 40 peer-reviewed studies that met predefined inclusion criteria. The primary focus was on evaluating the temporal dynamics, diagnostic utility, and prognostic relevance of CRP, IL-6, and PCT in patients with acute ischemic stroke. Results. CRP was identified as a sensitive marker of systemic inflammation, with plasma levels rising within 6–12 hours post-stroke and peaking at 24–48 hours. Levels exceeding 10 mg/L were associated with larger infarct size, increased risk of aspiration pneumonia, and poor functional outcomes. IL-6, a key cytokine in the acute-phase response, was found to correlate with infarct volume, blood–brain barrier disruption, and the risk of early neurological deterioration. Elevated IL-6 (>20 pg/mL) indicated severe systemic immune activation and predicted complications such as pneumonia and sepsis. PCT, a specific marker of bacterial infection, was useful in distinguishing post-stroke systemic inflammation from infectious processes. A PCT level >0.25 ng/mL within 48 hours post-admission signaled a high risk of bacterial complications, enabling timely antimicrobial intervention. Conclusion. CRP, IL-6, and PCT have significant diagnostic and prognostic utility in the intensive care management of ischemic stroke. Regular monitoring of these biomarkers enhances risk stratification, guides therapeutic decision-making, and facilitates early identification of infectious and inflammatory complications, ultimately improving patient outcomes.

16 December 2025 in Proceeding of the Shevchenko Scientific Society. Medical Sciences
Verified
Journal Article
Closed access
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
OKOlena Kochnieva
Olena Kochnieva
OKOlena Kotsar
Olena Kotsar
OKOksana Kauk
Oksana Kauk
OPOlena Pionova
Olena Pionova
MKMaksym Kovalov
Maksym Kovalov
Background. The nasopharynx is a critical mucosal barrier where commensals maintain immune balance and prevent pathogen colonization. Corynebacterium accolens and Dolosigranulum pigrum are linked to reduced pneumococcal carriage, fewer viral–bacterial coinfections, and modulation of host immunity. Their metabolites—short-chain fatty acids, nitric oxide, bacteriocins—reinforce epithelial integrity and regulate NF-κB, JAK/STAT, TGF-β/STAT3, promoting Treg cells. Natural effects remain insufficient for therapy. CRISPR/Cas now enables programming these commensals into “living probiotics” that deliver therapeutic molecules in a context-specific manner. Objective: To evaluate C. accolens and D. pigrum as microbial therapy candidates and propose a CRISPR/Cas9 framework for engineering probiotics to modulate mucosal immunity, exclude pathogens, and transmit anti-inflammatory signals. Methods. A systematic review (2005-2025) was conducted in PubMed, Scopus, Web of Science, EMBASE, Google Scholar using terms: “nasopharyngeal microbiome,” “C. accolens,” “D. pigrum,” “CRISPR editing,” “probiotics,” “mucosal immunity.” Eligible studies covered genomic, proteomic, metabolomic features, immune interactions, CRISPR editing in probiotics, and preclinical/in silico models. Excluded: unrelated niches, insufficient methods, and non-CRISPR work. Data were synthesized into five topics: ecological roles, molecular/secretome features, CRISPR advances, biosafety design, and validation strategies. Results. Both taxa emerged as keystone members of the nasopharyngeal microbiome. Genomics revealed stable chromosome organization, no virulence genes, and pathways for SCFA biosynthesis, lipid metabolism, and adhesion. Proteomic and metabolomic studies confirmed secretion of antimicrobial peptides, bacteriocins, and nitric oxide, reducing pathogens and modulating immunity. Functional assays showed TLR2/6 activation, NF-κB inhibition, STAT3/TGF-β promotion, and IL-10 induction, strengthening barriers, enhancing IgA, and favoring regulatory immunity. A CRISPR design was proposed for C. accolens, featuring an IL-10 cassette under an inflammation-inducible promoter, kill switches, auxotrophy, and self-limiting nuclease activity. In silico modeling confirmed ecological compatibility and circuit stability. Validation was conducted across in silico prediction, in vitro epithelium–MALT co-cultures, and in vivo murine models, with checkpoints for genomic stability, tolerance, and the absence of systemic spread. Personalization included microbiome-guided strain selection, prebiotic co-formulation, and biofilm assays, ensuring therapeutic expression only under inflammation. Conclusions. CRISPR-edited nasopharyngeal commensals are a promising therapeutic platform. C. accolens and D. pigrum combine stability, safety, and intrinsic immunomodulatory capacity, amplified by precise engineering. Inflammation-inducible IL-10 circuits enable localized, context-specific mucosal immunomodulation. Biosafety modules minimize ecological risk and secure evolutionary stability. Such engineered strains may deliver robust, personalized, clinically relevant interventions for infectious and inflammatory airway diseases.

29 December 2025 in Ukrainian Neurosurgical Journal
Verified
Journal Article
Open access
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
OKOksana I. Kauk
Oksana I. Kauk
SSSvitlana O. Stetsenko
Svitlana O. Stetsenko
SRSvitlana V. Rykhlik
Svitlana V. Rykhlik
Objective: To investigate morphofunctional changes of the neuro-glial-vascular interface in children with metabolic intoxications, particularly in acetonemic syndrome and hyperammonemia. Materials and methods: A systematic literature review with elements of narrative analysis was conducted following PRISMA guidelines. Literature search was performed in PubMed/MEDLINE, Web of Science Core Collection, Scopus, and Cochrane Library for the period 1990-2024. Included studies involved children from birth to 18 years and investigated neurotoxic effects of acetonemic syndrome and hyperammonemia. Study quality was assessed using Newcastle-Ottawa Scale, AMSTAR-2, and SYRCLE tools. Results: Key morphofunctional disorders of the neuro-glial-vascular interface were identified: cytotoxic astrocytic swelling due to glutamine accumulation during ammonia detoxification; blood-brain barrier disruption with decreased expression of tight junction proteins (claudin-5, occludin, ZO-1); impaired energy metabolism due to glycolysis inhibition and mitochondrial dysfunction; excitotoxicity resulting from glutamate-glutamine cycle disruption; microglial activation with increased expression of CD68, Iba1, MHC II, and pro-inflammatory cytokine secretion. Conclusions: Morphofunctional changes of the neuro-glial-vascular interface with acetonemic syndrome and hyperammonemia are characterized by complex disruptions of blood-brain barrier (BBB) structure and function, energy metabolism, neurotransmitter balance, and neuroinflammatory processes. A personalized approach to diagnosis and treatment using biomarkers of BBB damage and neuroinflammation is necessary.

30 August 2026 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
PDF file
Yaroslav BondarenkoYaroslav Bondarenko
Yaroslav Bondarenko
OPOlena Pionova
Olena Pionova
LCLidiya Cherkashyna
Lidiya Cherkashyna
KKKateryna Krasovska
Kateryna Krasovska
LBLiliia Bobro
Liliia Bobro
OKOksana Kauk
Oksana Kauk
Aim: To evaluate systemic multi-organ ultrasound phenotyping using VScan Air™ CL for detecting subclinical abnormalities in healthy adults aged 18–45 years and develop an integrated scoring system (LUMINA System) for early risk stratification. Material and methods: A prospective cohort study (2010–2025) enrolled 188 clinically healthy adults with normal biochemical markers, stratified into three age groups (18–26, 27–35, 36–45 years). Standardized ultrasound assessments of liver, kidneys, carotid arteries, heart, and thyroid were performed. The LUMINA System (score range: 0–29) integrated findings across organ systems. Results: Subclinical abnormalities were detected in 79.8% of participants despite normal laboratory values. Early liver steatosis occurred in 20.7%, correlating with higher BMI, triglycerides, and HOMA-IR. Increased renal echogenicity was found in 28–35% despite preserved kidney function. Carotid intima-media thickness exceeded the 75th percentile in 22.6%, with progressive vascular stiffness. Thyroid abnormalities appeared in 47.35%, suggesting autoimmune activation. Mean LUMINA scores increased from 0.44±0.31 (18–26 years) to 12.12±3.68 (27–35 years), strongly correlating with BMI (r=0.68), waist circumference (r=0.71), and HOMA-IR (r=0.54). Conclusions: Systemic ultrasound phenotyping enables early detection of multi-organ abnormalities in young adults with normal laboratory profiles. The LUMINA System provides unified preclinical risk stratification, revealing that metabolic, vascular, and endocrine remodeling coexist years before disease onset, enhancing preventive medicine through personalized intervention.